ES395365A1 - Procedimiento para la obtencion de agentes anticonceptivos. - Google Patents

Procedimiento para la obtencion de agentes anticonceptivos.

Info

Publication number
ES395365A1
ES395365A1 ES395365A ES395365A ES395365A1 ES 395365 A1 ES395365 A1 ES 395365A1 ES 395365 A ES395365 A ES 395365A ES 395365 A ES395365 A ES 395365A ES 395365 A1 ES395365 A1 ES 395365A1
Authority
ES
Spain
Prior art keywords
orally effective
compositions
contraceptive method
luteal
progestogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES395365A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH1426670A external-priority patent/CH538283A/de
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Publication of ES395365A1 publication Critical patent/ES395365A1/es
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A61K31/585Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • A61K9/2018Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ES395365A 1970-09-25 1971-09-23 Procedimiento para la obtencion de agentes anticonceptivos. Expired ES395365A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH1426670A CH538283A (de) 1970-09-25 1970-09-25 Neue antikonzeptionelle Mittel
CH1252471 1971-08-26

Publications (1)

Publication Number Publication Date
ES395365A1 true ES395365A1 (es) 1974-07-16

Family

ID=25710428

Family Applications (1)

Application Number Title Priority Date Filing Date
ES395365A Expired ES395365A1 (es) 1970-09-25 1971-09-23 Procedimiento para la obtencion de agentes anticonceptivos.

Country Status (10)

Country Link
AT (1) AT320138B (es)
AU (1) AU461935B2 (es)
BE (1) BE773064A (es)
CA (1) CA962595A (es)
DE (1) DE2146239A1 (es)
ES (1) ES395365A1 (es)
FR (1) FR2107969B1 (es)
GB (1) GB1369061A (es)
IL (1) IL37765A (es)
NL (1) NL7113201A (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA939565B (en) 1993-12-21 1994-08-11 Applied Analytical Ind Inc Method for preparing low dose pharmaceutical products.

Also Published As

Publication number Publication date
AU461935B2 (en) 1975-06-12
GB1369061A (en) 1974-10-02
BE773064A (fr) 1972-03-24
NL7113201A (es) 1972-03-28
FR2107969A1 (es) 1972-05-12
IL37765A0 (en) 1972-02-29
FR2107969B1 (es) 1975-04-18
DE2146239A1 (de) 1972-03-30
AU3380671A (en) 1973-03-29
AT320138B (de) 1975-01-27
IL37765A (en) 1975-03-13
CA962595A (en) 1975-02-11

Similar Documents

Publication Publication Date Title
Tietze Fertility after discontinuation of intrauterine and oral contraception
SE7416039L (es)
ES321779A1 (es) Un metodo para elaborar composiciones farmaceuticas.
NL173707C (nl) Samenstel van intra-uterine anticonceptiemiddel en bijbehorende inbrenghuls.
ES380943A1 (es) Un procedimiento para preparar una composicion anastesica adecuada para administracion parenteral.
ES370058A1 (es) Procedimiento para la preparacion de composiciones farma- ceuticas efervescentes.
NL7609559A (nl) Werkwijze ter bereiding van oxazolidinonen alsmede geneeskrachtige middelen die deze ver- bindingen als actieve component bevatten.
ES395365A1 (es) Procedimiento para la obtencion de agentes anticonceptivos.
Dionne et al. A double-blind comparison of two oral contraceptives containing 50 mu g. and 30 mu g. ethinyl estradiol
ES319318A1 (es) Procedimiento para la preparaciën de una composiciën anticonceptiva
FR3195M (fr) Compositions pharmaceutiques comprenant des dérivés de thébaine.
GB1116795A (en) An oral contraceptive preparation
ES283585A1 (es) Un procedimiento para la preparación de una composición terapéutica
ES287586A1 (es) Un procedimiento para la preparación de una composición terapéutica
NL142593B (nl) Werkwijze voor de bereiding van raubasine bevattende samenstellingen en doseringseenheden bereid volgens deze werkwijze.
ES430307A1 (es) Un metodo para la preparacion de una formulacion inyectable de una sola fase.
ES350825A1 (es) Procedimiento para la preparacion de 2-azidoacetofenonoxima.
ES430308A1 (es) Un metodo para la preparacion de una formulacion inyectableen una sola fase.
BE619513A (fr) Dérivés le tétrahydroisoquinoléine, leur préparation et compositions pharmaceutiques en contenant
ES382135A2 (es) Procedimiento para la obtencion de agentes para mejorar la microcirculacion y el tratamiento de la senilidad.
GB1311680A (en) Contraceptive preparations and method of contraception
Swyer Thromboembolic disease and the steroidal content of oral contraceptives
ES349900A1 (es) Un procedimiento para la preparacion de composiciones far- maceuticas de esteroides clorosustituidos.
JPS52110816A (en) Medicines
HUP9903839A3 (en) Pharmaceutical compositions containing (s)-oxybutynin and (s)-desethyloxybutynin for the treatment of urinary incontinence